Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Planning and Dissemination Grant - Institute Community Support

University of Manitoba

$10,000.00

9th International Conference on Relaxin, Related Peptides, and Receptors

EF 2022-23

Résumé
The 9th International Conference on Relaxin, Related-Peptides and Receptors (RELAXIN 2023) brings together scientists, industry partners, and trainees to exchange their most recent findings, establish collaborations, discuss ideas, and develop new concepts for targeted therapeutic strategies. A main focus of this conference is to offer an international forum to research trainees and early career researchers (ECRs) where they can present their scientific work and establish collaborations to build their careers. We purposefully chose this in-person venue to encourage communications and foster personal interactions to facilitate new and reinvigorate existing collaborations between scientists and/or industry partners. Our conference benefits trainees (including graduate students and post-doctoral fellows), early, mid, and late career researchers. We particularly want to inspire trainees at all levels and ECRs to "stick with it" and include relaxin/RXFP research as part of their future scientific careers. To ensure trainee participation, their travel expenses will be supported by the Steinetz fund (USA), the Geoff Tregear scholarship fund (AUS), and Zeiss Canada. We have planned special events for professional development, scientific journal workshops and public lectures that highlight how their research in this field has affected minorities and marginalized groups. Three keynote speakers highlight cutting-edge discoveries on pioneering cryo-EM work to reveal RXFP1 modes of activation, new immunomodulatory roles of relaxin in cancer, and the trials and tribulations of novel RXFP small molecule in the pipeline for clinical applications. These contributions provide the framework for the main event at RELAXIN 2023, which highlights presentations by trainees and their PIs from labs across the world featuring their discoveries in relaxin-like/RXFP research and pursuing new drug designs for clinical trials. This includes Canadian cancer researchers and their trainees.
Programme
Planning and Dissemination Grant - Institute Community Support
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
480623
Name
Klonisch Thomas
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Planning and Dissemination Grants
Projecttitle
9th International Conference on Relaxin, Related Peptides, and Receptors
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Manitoba
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Cancer; Cryo-Em Structure/Function; Fibrosis; G Protein Coupled Receptors; Immunomodulation; Receptor Analogues; Relaxin-Like Hormones; Rxfp Small Molecules
Abstract
The 9th International Conference on Relaxin, Related-Peptides and Receptors (RELAXIN 2023) brings together scientists, industry partners, and trainees to exchange their most recent findings, establish collaborations, discuss ideas, and develop new concepts for targeted therapeutic strategies. A main focus of this conference is to offer an international forum to research trainees and early career researchers (ECRs) where they can present their scientific work and establish collaborations to build their careers. We purposefully chose this in-person venue to encourage communications and foster personal interactions to facilitate new and reinvigorate existing collaborations between scientists and/or industry partners. Our conference benefits trainees (including graduate students and post-doctoral fellows), early, mid, and late career researchers. We particularly want to inspire trainees at all levels and ECRs to "stick with it" and include relaxin/RXFP research as part of their future scientific careers. To ensure trainee participation, their travel expenses will be supported by the Steinetz fund (USA), the Geoff Tregear scholarship fund (AUS), and Zeiss Canada. We have planned special events for professional development, scientific journal workshops and public lectures that highlight how their research in this field has affected minorities and marginalized groups. Three keynote speakers highlight cutting-edge discoveries on pioneering cryo-EM work to reveal RXFP1 modes of activation, new immunomodulatory roles of relaxin in cancer, and the trials and tribulations of novel RXFP small molecule in the pipeline for clinical applications. These contributions provide the framework for the main event at RELAXIN 2023, which highlights presentations by trainees and their PIs from labs across the world featuring their discoveries in relaxin-like/RXFP research and pursuing new drug designs for clinical trials. This includes Canadian cancer researchers and their trainees.
Competitiondate
202302
Approvedterm2
1 yr 0 mth
Pinamesdelim
Klonisch, Thomas
Approvedterm
1 an 0 mois
Cihrcontribution2
ICR~ $10,000~ $0~